Coumarin

Identification

Generic Name
Coumarin
DrugBank Accession Number
DB04665
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 146.1427
Monoisotopic: 146.036779436
Chemical Formula
C9H6O2
Synonyms
  • 1,2-benzopyrone
  • 2H-1-benzopyran-2-one
  • 2H-benzo(b)pyran-2-one
  • Coumarinic lactone
  • Cumarin
External IDs
  • NSC-8774

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
TargetActionsOrganism
UCytochrome P450 2A6Not AvailableHumans
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism

Hover over products below to view reaction partners

Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AbataceptThe metabolism of Coumarin can be increased when combined with Abatacept.
AbciximabThe risk or severity of bleeding can be increased when Abciximab is combined with Coumarin.
AbrocitinibThe metabolism of Abrocitinib can be decreased when combined with Coumarin.
AceclofenacThe risk or severity of bleeding and hemorrhage can be increased when Aceclofenac is combined with Coumarin.
AcemetacinThe risk or severity of bleeding and hemorrhage can be increased when Coumarin is combined with Acemetacin.
Food Interactions
  • Avoid herbs and supplements with anticoagulant/antiplatelet activity. Examples include garlic, ginger, bilberry, danshen, piracetam, and ginkgo biloba.
  • Ensure consistent Vitamin K intake.

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as coumarins and derivatives. These are polycyclic aromatic compounds containing a 1-benzopyran moiety with a ketone group at the C2 carbon atom (1-benzopyran-2-one).
Kingdom
Organic compounds
Super Class
Phenylpropanoids and polyketides
Class
Coumarins and derivatives
Sub Class
Not Available
Direct Parent
Coumarins and derivatives
Alternative Parents
1-benzopyrans / Pyranones and derivatives / Benzenoids / Heteroaromatic compounds / Lactones / Oxacyclic compounds / Organooxygen compounds / Organic oxides / Hydrocarbon derivatives
Substituents
1-benzopyran / Aromatic heteropolycyclic compound / Benzenoid / Benzopyran / Coumarin / Heteroaromatic compound / Hydrocarbon derivative / Lactone / Organic oxide / Organic oxygen compound
Molecular Framework
Aromatic heteropolycyclic compounds
External Descriptors
coumarins (CHEBI:28794) / coumarins, Phenylpropanoids (C05851) / a coumarin (COUMARIN)
Affected organisms
Not Available

Chemical Identifiers

UNII
A4VZ22K1WT
CAS number
91-64-5
InChI Key
ZYGHJZDHTFUPRJ-UHFFFAOYSA-N
InChI
InChI=1S/C9H6O2/c10-9-6-5-7-3-1-2-4-8(7)11-9/h1-6H
IUPAC Name
2H-chromen-2-one
SMILES
O=C1OC2=CC=CC=C2C=C1

References

Synthesis Reference

Ernst-Christian Witte, Peter Neubert, Androniki Roesch, "2H-1-benzopyran-2-one derivatives, processes for the preparation thereof and pharmaceutical compositions containing them." U.S. Patent US4670439, issued May, 1974.

US4670439
General References
Not Available
Human Metabolome Database
HMDB0001218
KEGG Compound
C05851
PubChem Compound
323
PubChem Substance
46509134
ChemSpider
13848793
BindingDB
12342
RxNav
2898
ChEBI
28794
ChEMBL
CHEMBL6466
ZINC
ZINC000000074709
PharmGKB
PA134521193
PDBe Ligand
COU
Wikipedia
Coumarin
PDB Entries
1z10 / 2h90 / 2pmj / 2pwb / 3crb / 3l5m / 3l66 / 3l68 / 4uti / 4utl

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
4CompletedTreatmentChronic Venous Insufficiency (CVI)1
4CompletedTreatmentDeep Vein Thrombosis / Pulmonary Embolism1
1CompletedTreatmentHypertriglyceridemias1
Not AvailableCompletedNot AvailableIschemic Stroke1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility1.0 mg/mLALOGPS
logP1.72ALOGPS
logP1.78Chemaxon
logS-2.2ALOGPS
pKa (Strongest Basic)-6.9Chemaxon
Physiological Charge0Chemaxon
Hydrogen Acceptor Count1Chemaxon
Hydrogen Donor Count0Chemaxon
Polar Surface Area26.3 Å2Chemaxon
Rotatable Bond Count0Chemaxon
Refractivity41.55 m3·mol-1Chemaxon
Polarizability14.36 Å3Chemaxon
Number of Rings2Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleYesChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
PropertyValueProbability
Human Intestinal Absorption+0.9912
Blood Brain Barrier+0.9565
Caco-2 permeable+0.9155
P-glycoprotein substrateNon-substrate0.6697
P-glycoprotein inhibitor INon-inhibitor0.854
P-glycoprotein inhibitor IINon-inhibitor0.8663
Renal organic cation transporterNon-inhibitor0.8301
CYP450 2C9 substrateNon-substrate0.7966
CYP450 2D6 substrateNon-substrate0.9117
CYP450 3A4 substrateNon-substrate0.7139
CYP450 1A2 substrateInhibitor0.9117
CYP450 2C9 inhibitorNon-inhibitor0.6943
CYP450 2D6 inhibitorNon-inhibitor0.9105
CYP450 2C19 inhibitorNon-inhibitor0.5
CYP450 3A4 inhibitorNon-inhibitor0.831
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.8115
Ames testNon AMES toxic0.887
CarcinogenicityNon-carcinogens0.9412
BiodegradationReady biodegradable0.5884
Rat acute toxicity2.4622 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.8702
hERG inhibition (predictor II)Non-inhibitor0.9474
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
GC-MS Spectrum - GC-MSGC-MSsplash10-014v-6900000000-3e901733dc003512f338
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-0gba-2900000000-12d24ebfbc2cbaa9d2e0
GC-MS Spectrum - EI-BGC-MSsplash10-00kb-8900000000-89e86d11a0dc2841af42
GC-MS Spectrum - EI-BGC-MSsplash10-014i-7900000000-25bab36f91f71ac65817
GC-MS Spectrum - EI-BGC-MSsplash10-02tj-9600000000-4a54f8d648a87a9c5811
GC-MS Spectrum - GC-MSGC-MSsplash10-014v-6900000000-3e901733dc003512f338
Mass Spectrum (Electron Ionization)MSsplash10-00kb-9700000000-7a649c1e257a7ad17b9d
MS/MS Spectrum - Quattro_QQQ 10V, Positive (Annotated)LC-MS/MSsplash10-0002-0900000000-6ef9288c71771dd56774
MS/MS Spectrum - Quattro_QQQ 25V, Positive (Annotated)LC-MS/MSsplash10-0006-9100000000-93154d9b40c4d0fdd1ae
MS/MS Spectrum - Quattro_QQQ 40V, Positive (Annotated)LC-MS/MSsplash10-014i-9000000000-72ec22913d1d574be75b
MS/MS Spectrum - EI-B (HITACHI RMU-7L) , PositiveLC-MS/MSsplash10-00kb-8900000000-89e86d11a0dc2841af42
MS/MS Spectrum - EI-B (HITACHI RMU-6M) , PositiveLC-MS/MSsplash10-014i-7900000000-25bab36f91f71ac65817
MS/MS Spectrum - EI-B (JEOL JMS-AX-505-H) , PositiveLC-MS/MSsplash10-02tj-9600000000-6e4062e14fc72534c96a
MS/MS Spectrum - DI-ESI-qTof , PositiveLC-MS/MSsplash10-015a-0900000100-6ae81e23a1a6770a9f59
MS/MS Spectrum - Linear Ion Trap , negativeLC-MS/MSsplash10-000i-9200000000-38161abf759afe5aa970
LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-0002-0900000000-c06b97954c5a847401e8
LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-0002-1900000000-6f05165347e6221503b0
LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-0f6x-8900000000-6e9532ad6b20b76b3d4b
LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-0006-9300000000-3f95abb339f5c1aea790
LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-0006-9200000000-c404268b480236aaf197
LC-MS/MS Spectrum - LC-ESI-QQ , positiveLC-MS/MSsplash10-0f6x-9500000000-da852779b618f093b767
LC-MS/MS Spectrum - LC-ESI-QQ , positiveLC-MS/MSsplash10-0006-9300000000-c29bd55b8ca9510aec2f
LC-MS/MS Spectrum - LC-ESI-QQ , positiveLC-MS/MSsplash10-0006-9100000000-161d49edf4310e8a785c
LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-0002-0900000000-3777f28f5438e1f09160
LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-0udi-0900000000-bfe432f57faff8d62318
LC-MS/MS Spectrum - LC-ESI-QTOF , positiveLC-MS/MSsplash10-0089-0000800900-d301ec3931fa0374d57a
MS/MS Spectrum - Linear Ion Trap , positiveLC-MS/MSsplash10-0690-7900000000-975e23de8283da2b67ba
MS/MS Spectrum - Linear Ion Trap , positiveLC-MS/MSsplash10-001i-0900000000-eb06aa4e28f43c98e973
LC-MS/MS Spectrum - LC-ESI-QFT , positiveLC-MS/MSsplash10-0002-0900000000-0ac49ca1676aa2241ed9
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSsplash10-0002-0900000000-57f921c228985a349da3
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSsplash10-0002-0900000000-7e5abce0d31490f300fe
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSsplash10-0udj-0900000000-b32c08449c9f3cb13d35
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSsplash10-014j-0900000000-9083ca8fd68cd98076e7
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSsplash10-0udi-2900000000-f38c59c7c0deb189a201
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSsplash10-014j-2900000000-5c5ebefc44e2d33b2fe7
1H NMR Spectrum1D NMRNot Applicable
1H NMR Spectrum1D NMRNot Applicable
13C NMR Spectrum1D NMRNot Applicable
Predicted 1H NMR Spectrum1D NMRNot Applicable
Predicted 13C NMR Spectrum1D NMRNot Applicable
[1H,13C] 2D NMR Spectrum2D NMRNot Applicable
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-127.1017794
predicted
DarkChem Lite v0.1.0
[M-H]-127.2178794
predicted
DarkChem Lite v0.1.0
[M-H]-126.9930794
predicted
DarkChem Lite v0.1.0
[M-H]-127.930466
predicted
DeepCCS 1.0 (2019)
[M+H]+128.2137794
predicted
DarkChem Lite v0.1.0
[M+H]+128.2887794
predicted
DarkChem Lite v0.1.0
[M+H]+128.1407794
predicted
DarkChem Lite v0.1.0
[M+H]+130.7934
predicted
DeepCCS 1.0 (2019)
[M+Na]+127.5417794
predicted
DarkChem Lite v0.1.0
[M+Na]+127.8572794
predicted
DarkChem Lite v0.1.0
[M+Na]+127.7646794
predicted
DarkChem Lite v0.1.0
[M+Na]+139.87288
predicted
DeepCCS 1.0 (2019)

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Kind
Protein
Organism
Humans
Pharmacological action
Unknown
General Function
Steroid hydroxylase activity
Specific Function
Exhibits a high coumarin 7-hydroxylase activity. Can act in the hydroxylation of the anti-cancer drugs cyclophosphamide and ifosphamide. Competent in the metabolic activation of aflatoxin B1. Const...
Gene Name
CYP2A6
Uniprot ID
P11509
Uniprot Name
Cytochrome P450 2A6
Molecular Weight
56501.005 Da

Enzymes

Kind
Protein
Organism
Humans
Pharmacological action
No
Actions
Substrate
General Function
Steroid hydroxylase activity
Specific Function
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally un...
Gene Name
CYP2C9
Uniprot ID
P11712
Uniprot Name
Cytochrome P450 2C9
Molecular Weight
55627.365 Da
References
  1. Daly AK, Rettie AE, Fowler DM, Miners JO: Pharmacogenomics of CYP2C9: Functional and Clinical Considerations. J Pers Med. 2017 Dec 28;8(1). pii: jpm8010001. doi: 10.3390/jpm8010001. [Article]
  2. Flockhart Table of Drug Interactions [Link]

Drug created at September 11, 2007 17:49 / Updated at July 14, 2020 10:58